%0 Journal Article
%T Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.
%A Gervais A
%A Dirksen EHC
%A Pohl T
%A Bechtold-Peters K
%A Burkitt W
%A D'Alessio V
%A Greven S
%A Lennard A
%A Li X
%A Lössner C
%A Niu B
%A Reusch D
%A O'Riordan T
%A Shearer JW
%A Spencer D
%A Xu W
%A Yi L
%J Eur J Pharm Biopharm
%V 191
%N 0
%D 2023 Oct 13
%M 37582411
%F 5.589
%R 10.1016/j.ejpb.2023.08.008
%X Multi-attribute methods employing mass spectrometry are applied throughout the biopharmaceutical industry for product and process characterization purposes but are not yet widely accepted as a method for batch release and stability testing under the good manufacturing practice (GMP) regime, due to limited experience and level of comfort with the technical, compliance and regulatory aspects of its implementation at quality control (QC) laboratories. This article is the second part of a two-tiered publication aiming at providing guidance for implementation of the multi-attribute method by peptide mapping liquid chromatography mass spectrometry (MAM) in a QC laboratory. The first part [1] focuses on technical considerations, while this second part provides considerations related to GMP compliance and regulatory aspects. This publication has been prepared by a group of industry experts representing 14 globally acting major biotechnology companies under the umbrella of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Manufacturing & Quality Expert Group (MQEG).